Annual Total Long Term Liabilities
$0.00
-$2.22 M-100.00%
December 31, 2023
Summary
- As of February 26, 2025, TCRT annual total long term liabilities is $0.00, with the most recent change of -$2.22 million (-100.00%) on December 31, 2023.
- During the last 3 years, TCRT annual total long term liabilities has fallen by -$4.00 million (-100.00%).
- TCRT annual total long term liabilities is now -100.00% below its all-time high of $48.23 million, reached on December 31, 2015.
Performance
TCRT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 26, 2025, TCRT quarterly total long term liabilities is $0.00, unchanged on September 30, 2024.
- Over the past year, TCRT quarterly long term liabilities has stayed the same.
- TCRT quarterly long term liabilities is now -100.00% below its all-time high of $163.97 million, reached on June 30, 2016.
Performance
TCRT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TCRT Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | 0.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% |
TCRT Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Alaunos Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2023 | - | $864.00 K(-29.5%) |
| Jun 2023 | - | $1.23 M(-40.7%) |
| Mar 2023 | - | $2.07 M(-6.8%) |
| Dec 2022 | $2.22 M(-89.3%) | $2.22 M(-6.2%) |
| Sep 2022 | - | $2.36 M(-66.1%) |
| Jun 2022 | - | $6.98 M(-52.3%) |
| Mar 2022 | - | $14.63 M(-29.5%) |
| Dec 2021 | $20.77 M(+419.8%) | $20.77 M(+23.0%) |
| Sep 2021 | - | $16.88 M(+245.2%) |
| Jun 2021 | - | $4.89 M(+26.4%) |
| Mar 2021 | - | $3.87 M(-3.1%) |
| Dec 2020 | $4.00 M(+153.2%) | $4.00 M(+141.4%) |
| Sep 2020 | - | $1.66 M(+43.5%) |
| Jun 2020 | - | $1.15 M(-15.4%) |
| Mar 2020 | - | $1.36 M(-13.6%) |
| Dec 2019 | $1.58 M(>+9900.0%) | $1.58 M(+143.9%) |
| Sep 2019 | - | $647.00 K(-16.8%) |
| Jun 2019 | - | $778.00 K(-17.9%) |
| Mar 2019 | - | $948.00 K(>+9900.0%) |
| Dec 2018 | $4000.00(-100.0%) | $4000.00(-99.8%) |
| Sep 2018 | - | $2.60 M(-95.0%) |
| Jun 2018 | - | $51.88 M(+0.7%) |
| Mar 2018 | - | $51.51 M(+37.1%) |
| Dec 2017 | $37.56 M(-11.6%) | $37.56 M(-3.9%) |
| Sep 2017 | - | $39.10 M(-4.3%) |
| Jun 2017 | - | $40.87 M(-3.8%) |
| Mar 2017 | - | $42.49 M(-0.1%) |
| Dec 2016 | $42.52 M(-11.8%) | $42.52 M(-3.3%) |
| Sep 2016 | - | $43.98 M(-73.2%) |
| Jun 2016 | - | $163.97 M(+251.9%) |
| Mar 2016 | - | $46.59 M(-3.4%) |
| Dec 2015 | $48.23 M(+8361.4%) | $48.23 M(-3.3%) |
| Sep 2015 | - | $49.89 M(>+9900.0%) |
| Jun 2015 | - | $487.00 K(-11.9%) |
| Mar 2015 | - | $553.00 K(-3.0%) |
| Dec 2014 | $570.00 K(-96.1%) | $570.00 K(-38.8%) |
| Sep 2014 | - | $932.00 K(-86.4%) |
| Jun 2014 | - | $6.84 M(-51.9%) |
| Mar 2014 | - | $14.24 M(-2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $14.58 M(-9.4%) | $14.58 M(+16.8%) |
| Sep 2013 | - | $12.48 M(+136.7%) |
| Jun 2013 | - | $5.27 M(+3.6%) |
| Mar 2013 | - | $5.09 M(-68.4%) |
| Dec 2012 | $16.09 M(-30.4%) | $16.09 M(-35.3%) |
| Sep 2012 | - | $24.88 M(-14.1%) |
| Jun 2012 | - | $28.97 M(+0.4%) |
| Mar 2012 | - | $28.84 M(+24.7%) |
| Dec 2011 | $23.14 M(-15.4%) | $23.14 M(-12.3%) |
| Sep 2011 | - | $26.39 M(-34.0%) |
| Jun 2011 | - | $40.00 M(-5.6%) |
| Mar 2011 | - | $42.37 M(+54.9%) |
| Dec 2010 | $27.36 M(+47.6%) | $27.36 M(+29.4%) |
| Sep 2010 | - | $21.14 M(+21.3%) |
| Jun 2010 | - | $17.43 M(-44.9%) |
| Mar 2010 | - | $31.62 M(+70.6%) |
| Dec 2009 | $18.54 M(>+9900.0%) | $18.54 M(+2683.3%) |
| Sep 2009 | - | $666.00 K(+76.2%) |
| Jun 2009 | - | $378.00 K(+110.0%) |
| Mar 2009 | - | $180.00 K(+210.3%) |
| Dec 2008 | $58.00 K(+13.7%) | $58.00 K(-4.8%) |
| Sep 2008 | - | $60.90 K(+0.8%) |
| Jun 2008 | - | $60.40 K(+2.4%) |
| Mar 2008 | - | $59.00 K(+15.7%) |
| Dec 2007 | $51.00 K(+24.1%) | $51.00 K(+40.5%) |
| Sep 2007 | - | $36.30 K(-16.7%) |
| Jun 2007 | - | $43.60 K(+6.6%) |
| Mar 2007 | - | $40.90 K(-0.5%) |
| Dec 2006 | $41.10 K(+15.4%) | $41.10 K(+2.8%) |
| Sep 2006 | - | $40.00 K(+7.2%) |
| Jun 2006 | - | $37.30 K(+2.5%) |
| Mar 2006 | - | $36.40 K(+2.2%) |
| Dec 2005 | $35.60 K(>+9900.0%) | $35.60 K(>+9900.0%) |
| Sep 2003 | - | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2002 | - | $7100.00(+373.3%) |
| Jun 2002 | - | $1500.00(+400.0%) |
| Mar 2002 | - | $300.00(-94.5%) |
| Dec 2001 | $5500.00 | $5500.00(+37.5%) |
| Sep 2001 | - | $4000.00(0.0%) |
| Jun 2001 | - | $4000.00 |
FAQ
- What is Alaunos Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual total long term liabilities year-on-year change?
- What is Alaunos Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly long term liabilities year-on-year change?
What is Alaunos Therapeutics annual total long term liabilities?
The current annual total long term liabilities of TCRT is $0.00
What is the all time high annual total long term liabilities for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual total long term liabilities is $48.23 M
What is Alaunos Therapeutics annual total long term liabilities year-on-year change?
Over the past year, TCRT annual total long term liabilities has changed by -$2.22 M (-100.00%)
What is Alaunos Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of TCRT is $0.00
What is the all time high quarterly long term liabilities for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly total long term liabilities is $163.97 M
What is Alaunos Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, TCRT quarterly total long term liabilities has changed by $0.00 (0.00%)